Good morning and happy Friday. I’m off today, but I’ll talk to you next week. Highlights from yesterday’s summit For me, the top moment from yesterday’s...
If the U.S. wants to hold on to its title as the world’s top biotech innovator, it might want to take a page out of China’s...
WASHINGTON — Autism scientists and advocates met Thursday to develop an agenda for autism research, the first gathering of a group that hopes to command the...
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your...
A high-dose version of Novo Nordisk’s injectable obesity drug Wegovy received U.S. approval, the company said Thursday, providing it with a new catalyst as it tries...
Regulators are trying to push drug development into a post-animal testing era. Meanwhile, a Jennifer Doudna-founded company is edging toward successful CAR-T therapy done in vivo, and...
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your...
It’s Breakthrough Summit East day! If you weren’t able to snag a ticket to join us in New York City to hear from the leaders advancing...
Top of the morning to you, and a fine one it is. Despite dreary, gray skies and chilly temperatures, the Pharmalot campus is humming with activity,...
Scan to Read